Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Singular Genomics Systems Inc (NQ: OMIC )

6.640 -0.550 (-7.65%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 856
Open 7.200
Bid (Size) 3.000 (2)
Ask (Size) 7.960 (2)
Prev. Close 7.190
Today's Range 6.640 - 7.200
52wk Range 6.640 - 19.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q2 2024
OMIC stock results show that Singular Genomics Sys beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire

Performance

YTD
-54.36%
-54.36%
1 Month
-17.00%
-17.00%
3 Month
-43.68%
-43.68%
6 Month
-58.16%
-58.16%
1 Year
-56.00%
-56.00%

More News

Read More
Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Sys: Q4 Earnings Insights
Via Benzinga
Preview: Singular Genomics Sys's Earnings
Via Benzinga
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023
Via InvestorPlace
Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
Via Benzinga
Singular Genomics Announces 1-for-30 Reverse Stock Split
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Recap: Singular Genomics Sys Q3 Earnings
Via Benzinga
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Earnings Scheduled For March 18, 2024
Via Benzinga
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.